Quick answers
- What is Jalyn?
- Jalyn is a brand name of Dutasteride and tamsulosin hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Jalyn product in 1 strength and form.
- Who makes Jalyn?
- Waylis Therap holds the FDA application for Jalyn (NDA022460, approved June 14, 2010).
- Is there a generic or store brand of Jalyn?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Jalyn product, 3 of them generic. Ask your pharmacist whether one is right for you.
- Has Jalyn been recalled?
- No recall linked to Jalyn products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Jalyn is
Each Jalyn product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Dutasteride and tamsulosin hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| dutasteride 0.5 mg · tamsulosin hydrochloride 0.4 mg capsule (oral) | Jalyn | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Dutasteride and tamsulosin hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022460 | Waylis Therap | June 14, 2010 | 1 |
Companies that list Jalyn
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Jalyn products.
- Waylis Therapeutics1 product
Recalls
No recall linked to Jalyn products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.